此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

左 vs 左随机临床试验

2026年11月8日 更新者:Mihail Gabriel Chelu、Baylor College of Medicine

在左心室射血分数 (LVEF) ≤ 50% 且具有宽 QRS 波群 (>130 ms) 的心力衰竭 (HF) 患者中使用希氏/左束支起搏与双心室起搏与左心室心外膜导线的心脏再同步化治疗或有/预期 >40% 起搏随机临床试验

The investigators aim to prospectively test the comparative effectiveness of His or Left bundle branch pacing in relation to patient centered outcomes (quality of life, physical activity, heart failure hospitalization, mortality) and comparative safety in relation to device-related complications and re-interventions (e.g., lead dislodgement, infection) relative to standard of care biventricular pacing in patients with heart failure due to left ventricular systolic dysfunction (LVEF≤50%) and with either a wide QRS (≥130 ms) or with/anticipated >40% pacing who are already receiving current standard heart failure pharmacological therapy.

研究概览

详细说明

In this prospective, randomized, multi-center clinical trial, the investigators aim to prospectively evaluate the comparative effectiveness His or Left bundle branch pacing (His/LBBP) vs. biventricular pacing (BiVP) in patients with heart failure due to left ventricular systolic dysfunction (LVEF≤50%) and with either a wide QRS (≥130 ms) or with/anticipated >40% pacing who are already receiving current standard heart failure pharmacological therapy by assessing all cause death and heart failure hospitalization at the end of the study.

Additional formal secondary objectives include evaluation disease-specific quality and psychological adjustment changes at 1 year after device implant and evaluation of a composite of death of any cause or heart failure hospitalization or more >15% increase in the left ventricular end-systolic volume index at the end of the study.

研究类型

介入性

注册 (估计的)

2136

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

学习地点

      • Calgary、加拿大
        • 招聘中
        • University of Calgary
        • 接触:
          • Nirav Bhagat
        • 首席研究员:
          • Derek Exner
      • Kitchener、加拿大
        • 招聘中
        • Waterloo Wellington Cardiovascular Research Institute (WWCRI) - St. Mary's General Hospital
        • 接触:
          • Mary Radyk
        • 首席研究员:
          • Claus Rinne
      • Montreal、加拿大
        • 招聘中
        • Research Institute of the McGill University Health Centre (RI-MUHC) - MUHC, Montreal General Hospital
        • 首席研究员:
          • Jacqueline Joza
        • 接触:
          • Fiorella Rafti
      • Québec、加拿大
        • 招聘中
        • Université Laval
        • 首席研究员:
          • Francois Philippon, MD
        • 接触:
    • Alberta
      • Edmonton、Alberta、加拿大
        • 招聘中
        • Mazankowski Alberta Heart Institute/University of Alberta
        • 接触:
        • 首席研究员:
          • Evan Martow, MD
    • British Columbia
      • Vancouver、British Columbia、加拿大
        • 招聘中
        • University of British Columbia
        • 首席研究员:
          • Jason Andrade, MD
        • 接触:
      • Victoria、British Columbia、加拿大
        • 招聘中
        • Victoria Cardiac Arrhythmia Trials (VCAT) Inc.
        • 首席研究员:
          • Laurence Sterns, MD
        • 接触:
    • Nova Scotia
      • Halifax、Nova Scotia、加拿大
        • 招聘中
        • Nova Scotia Health Authority
        • 首席研究员:
          • Ratika Parkash, MD
        • 接触:
    • Ontario
      • Hamilton、Ontario、加拿大
        • 招聘中
        • Hamilton Health Sciences (HHS)
        • 首席研究员:
          • Jorge Wong, MD
        • 接触:
      • Newmarket、Ontario、加拿大
        • 招聘中
        • Newmarket Electrophysiology Research Group Inc. (NERG)
        • 首席研究员:
          • Mouhannad Sadek, MD
        • 接触:
      • Ottawa、Ontario、加拿大
        • 招聘中
        • University of Ottawa Heart Institute
        • 接触:
        • 首席研究员:
          • Calum Redpath, MD
      • Toronto、Ontario、加拿大
        • 招聘中
        • Sunnybrook Research Institute
        • 首席研究员:
          • Christopher Cheung, MD
        • 接触:
    • Quebec
      • Montreal、Quebec、加拿大
        • 招聘中
        • Montreal Heart Institute
        • 接触:
        • 首席研究员:
          • Alexandre Raymond-Paquin, MD
      • Saint-Jean-sur-Richelieu、Quebec、加拿大
    • Arizona
      • Gilbert、Arizona、美国、85297
        • 招聘中
        • Mercy Gilbert & Chandler Regional Medical Centers, Gilbert AZ
        • 首席研究员:
          • Jaskanwal Bisla, MD
        • 接触:
      • Tucson、Arizona、美国、85719
        • 招聘中
        • University of Arizona College of Medicine- Phoenix
        • 接触:
        • 首席研究员:
          • Michael Zawaneh, MD
    • Arkansas
      • Little Rock、Arkansas、美国、72205
        • 招聘中
        • University of Arkansas for Medical Sciences (UAMS)
        • 接触:
        • 首席研究员:
          • Subodh Devabhaktuni, MD
    • California
      • La Jolla、California、美国、92093
        • 招聘中
        • University of California San Diego
        • 接触:
        • 首席研究员:
          • Farshad Raissi, MD
    • Colorado
      • Denver、Colorado、美国、80217
        • 招聘中
        • University of Colorado (Anschutz Medical Campus)
        • 接触:
        • 首席研究员:
          • Matthew Zipse, MD
      • Littleton、Colorado、美国、80124
        • 招聘中
        • South Denver Cardiology Associates
        • 首席研究员:
          • Srikanth Sundaram, MD
        • 接触:
    • Connecticut
      • Hartford、Connecticut、美国、06102
        • 招聘中
        • Hartford Hospital
        • 首席研究员:
          • Eric Crespo, MD
        • 接触:
      • New Haven、Connecticut、美国、06511
        • 招聘中
        • Yale University
        • 接触:
        • 首席研究员:
          • Mark Blitzer, MD
    • Florida
      • Davie、Florida、美国、33328
        • 招聘中
        • Heart Rhythm Solutions
        • 接触:
        • 首席研究员:
          • Awais K Humayun, MD
      • Jacksonville、Florida、美国、32211
        • 招聘中
        • University of Florida Jacksonville
        • 接触:
        • 首席研究员:
          • Aditya Saini, MD
      • Miami Beach、Florida、美国、33140
        • 尚未招聘
        • Mount Sinai Medical Center of Florida, Inc.
        • 接触:
        • 首席研究员:
          • Jose Sleiman, MD
      • Palm Beach Gardens、Florida、美国、33418
        • 招聘中
        • Cleveland Clinic Florida
        • 首席研究员:
          • Ricardo Hernandez, MD
        • 接触:
      • South Pasadena、Florida、美国、33707
        • 尚未招聘
        • Florida Heart and Vascular, LLC dba Florida Heart Rhythm Specialist, PLLC
        • 首席研究员:
          • David Kenigsberg, MD
        • 接触:
      • Tampa、Florida、美国、33613
        • 招聘中
        • University of South Florida
        • 接触:
        • 首席研究员:
          • Bengt Herweg, MD
    • Illinois
      • Chicago、Illinois、美国、60637
        • 招聘中
        • University of Chicago
        • 接触:
          • Shahram Sarrafi
        • 首席研究员:
          • Gaurav Upadhyay, MD
      • Chicago、Illinois、美国、60612
        • 招聘中
        • Rush University
        • 接触:
          • Nusrat Jahan
        • 首席研究员:
          • Timothy Larsen, DO
      • Evanston、Illinois、美国、60208
        • 招聘中
        • Northwestern University
        • 接触:
        • 首席研究员:
          • Nishant Verma, MD
      • Naperville、Illinois、美国、60540
        • 邀请报名
        • CIS Clinical Research Corporation
    • Indiana
      • Indianapolis、Indiana、美国、46202
        • 招聘中
        • Trustees of Indiana University
        • 首席研究员:
          • Antonio Navarrete, MD
        • 接触:
    • Kentucky
      • Louisville、Kentucky、美国、40207
        • 招聘中
        • Baptist Health Louisville
        • 接触:
        • 首席研究员:
          • John Mandrola, MD
    • Massachusetts
      • Boston、Massachusetts、美国、02114
        • 招聘中
        • Massachusetts General Hospital
        • 接触:
        • 首席研究员:
          • Shaan Khurshid, MD
      • Boston、Massachusetts、美国、02215
        • 招聘中
        • Beth Israel Deaconess Medical Center
        • 首席研究员:
          • Andrew Locke, MD
        • 接触:
    • Minnesota
      • Rochester、Minnesota、美国、55905
        • 招聘中
        • Mayo Clinic
        • 首席研究员:
          • Yong-Mei Cha, MD
        • 接触:
    • New Jersey
      • Hackensack、New Jersey、美国、07601
        • 招聘中
        • HMH Hospitals Corporation
        • 接触:
        • 首席研究员:
          • Taya Glotzer, MD
      • Marlton、New Jersey、美国、08053
        • 招聘中
        • Virtua Health
        • 接触:
        • 首席研究员:
          • Aatish Garg, MD
      • Newark、New Jersey、美国、07112
        • 招聘中
        • Newark Beth Israel Medical Center
        • 接触:
        • 首席研究员:
          • David Man, MD
      • Ridgewood、New Jersey、美国、07450
        • 招聘中
        • The Valley Hospital, Inc.
        • 首席研究员:
          • Suneet Mittal, MD
        • 接触:
    • New Mexico
      • Albuquerque、New Mexico、美国、87102
        • 招聘中
        • Lovelace Medical Center
        • 接触:
          • Zinai Tellez
        • 首席研究员:
          • Sean Mazer
    • New York
      • New York、New York、美国、10021
        • 招聘中
        • Weill Cornell Medicine
        • 首席研究员:
          • Jim Cheung, MD
        • 接触:
      • New York、New York、美国、10029
        • 招聘中
        • Icahn School of Medicine at Mount Sinai
        • 首席研究员:
          • Jacob Koruth, MD
        • 接触:
      • New York、New York、美国、10032
        • 尚未招聘
        • Columbia University Medical Center/New York-Presbyterian Hospital (CUMC/NYPH)
        • 接触:
        • 首席研究员:
          • Ellie Coronmilas, MD
    • North Carolina
      • Asheville、North Carolina、美国、28803
        • 招聘中
        • MH Mission Hospital LLLP- Asheville Cardiology Associates
        • 接触:
        • 首席研究员:
          • Michael Manogue, MD
      • Chapel Hill、North Carolina、美国、27599
        • 招聘中
        • University of North Carolina
        • 首席研究员:
          • Anil Gehi, MD
        • 接触:
      • Charlotte、North Carolina、美国、28204
        • 招聘中
        • Novant Health
        • 接触:
          • Darren N Crawford
        • 首席研究员:
          • Thomas Kambur
    • Ohio
      • Cincinnati、Ohio、美国、45219
      • Cleveland、Ohio、美国、44195
        • 招聘中
        • Cleveland Clinic
        • 接触:
        • 首席研究员:
          • Roy Chung, MD
      • Cleveland、Ohio、美国、44109
        • 招聘中
        • The MetroHealth System
        • 接触:
        • 首席研究员:
          • Soufian Almahameed, MD
    • Oregon
      • Portland、Oregon、美国、97239
        • 招聘中
        • Oregon Health & Science University
        • 接触:
        • 首席研究员:
          • Eric Stecker, MD
    • Pennsylvania
      • Allentown、Pennsylvania、美国、18015
        • 招聘中
        • St. Luke's University Health Network
        • 接触:
        • 首席研究员:
          • Sudip Nanda, MD
      • Allentown、Pennsylvania、美国、18103
        • 招聘中
        • Lehigh Valley Hospital Inc.
        • 接触:
        • 首席研究员:
          • Babak Borzognia, MD
      • Lancaster、Pennsylvania、美国、17603
        • 招聘中
        • Penn Medicine Lancaster General
        • 首席研究员:
          • Matthew Bernabei, MD
        • 接触:
      • Philadelphia、Pennsylvania、美国、19104
        • 招聘中
        • University of Pennsylvania
        • 首席研究员:
          • Robert Schaller, MD
        • 接触:
      • Philadelphia、Pennsylvania、美国、19107
        • 招聘中
        • Thomas Jefferson University Hospital
        • 接触:
          • Mckenna Krall
        • 首席研究员:
          • Behzad Pavri
      • Pittsburgh、Pennsylvania、美国、15212
        • 招聘中
        • Allegheny-Singer Research Institute
        • 首席研究员:
          • Joshua Silverstein, MD
        • 接触:
      • Pittsburgh、Pennsylvania、美国、15213
        • 招聘中
        • University of Pittsburg
        • 首席研究员:
          • Krishna Kancharla, MD
        • 接触:
      • Scranton、Pennsylvania、美国、18510
        • 招聘中
        • Geisinger Commonwealth School of Medicine
        • 接触:
          • Grace E Hughes
        • 首席研究员:
          • Jess Oren, MD
    • South Carolina
      • Charleston、South Carolina、美国、29425
        • 招聘中
        • Medical University of South Carolina (MUSC)
        • 接触:
        • 首席研究员:
          • Anne Kroman, MD
      • Greenville、South Carolina、美国、29605
        • 尚未招聘
        • Prisma Health-Upstate
        • 接触:
        • 首席研究员:
          • Adam Barnett, MD
    • Texas
      • Arlington、Texas、美国、76011
        • 招聘中
        • Texas Health Research & Education Institute
        • 接触:
        • 首席研究员:
          • Theodore Takata, MD
      • Houston、Texas、美国、77030
        • 招聘中
        • Baylor College of Medicine
        • 首席研究员:
          • Mihail Chelu, MD
        • 接触:
          • Stephen Harold
          • 电话号码:(713) 798-7227
          • 邮箱:harold@bcm.edu
    • Utah
      • Salt Lake City、Utah、美国、84124
    • Vermont
      • Burlington、Vermont、美国、05402
        • 招聘中
        • University of Vermont
        • 接触:
        • 首席研究员:
          • Daniel Lustgarten, MD
    • Virginia
      • Charlottesville、Virginia、美国、22908
        • 招聘中
        • University of Virginia Health System
        • 首席研究员:
          • Rohit Malhotra
        • 接触:
          • Katie L Sullivan
      • Falls Church、Virginia、美国、22042
        • 招聘中
        • Inova Heart and Vascular Institute
        • 首席研究员:
          • Brett Atwater, MD
        • 接触:
      • Newport News、Virginia、美国、23606
        • 招聘中
        • Sentara Healthcare
        • 接触:
          • Linette Klevan
        • 首席研究员:
          • Erich Kiehl
      • Richmond、Virginia、美国、23284
        • 招聘中
        • Virginia Commonwealth University
        • 首席研究员:
          • Jordana Kron, MD
        • 接触:
          • Melissa Sears
    • Washington
      • Seattle、Washington、美国、98195
        • 招聘中
        • University of Washington
        • 接触:
        • 首席研究员:
          • Kristen Patton, MD

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Men and women 18 years of age or older.
  • A LVEF ≤ 50% within 6 months prior to enrollment.
  • Resting QRS duration ≥130 ms as evidenced by a historical 12-lead ECG prior to enrollment OR anticipated right ventricular pacing >40% OR device in place with right ventricular pacing > 40%.
  • Are optimized on HF guideline directed medical therapy according to current HF published guidelines OR patient's physician will make an effort to start all guideline-directed medical therapy and titrate doses up as permitted by the participant clinical status and co-morbidities prior to implantation procedure.

Exclusion Criteria:

  • Women who are pregnant, lactating, or plan to become pregnant during the course of the trial.
  • Participants with angiographic evidence of coronary disease who are candidates for coronary revascularization and are likely to undergo coronary artery bypass graft surgery or percutaneous coronary, intervention in the next three (3) months.
  • Enzyme-positive myocardial infarction within the past three (3) months prior to enrollment.
  • Coronary artery bypass graft surgery or percutaneous coronary intervention (balloon and/or stent angioplasty) within the past three (3) months prior to enrollment.
  • Reversible non-ischemic cardiomyopathy (e.g., acute viral myocarditis).
  • Participants with Chagas disease, cardiac sarcoidosis or amyloidosis.
  • Expected to receive left ventricular assist device or heart transplantation within 6 months.
  • Participants with primary severe valvular disease (e.g., aortic stenosis).
  • Have a life expectancy of less than 12 months.
  • Participants with irreversible brain damage from preexisting cerebral disease.
  • Participants with a contrast dye allergy unable or unwilling to undergo pretreatment with steroids and/or diphenhydramine.
  • Participants participating in any other interventional cardiovascular clinical trial.
  • Participants who would be unable to comply with the study's follow-up visit schedule; or
  • Participants who had any prior unsuccessful attempt at implantation of biventricular pacing (BiVP), His Bundle Pacing (HBP), or Left Bundle Branch Pacing (LBBP) device.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:三倍

武器和干预

参与者组/臂
干预/治疗
有源比较器:His/Left Bundle Branch Pacing (His/LBBP)

Patients with LVEF≤35% at entry will receive a His/LBB defibrillator which includes implantation of three leads, an endocardial right atrial lead, an endocardial right ventricular ICD lead, and an endocardial His-bundle or left bundle branch pacing lead directly pacing the intrinsic conduction system.

Patients with LVEF 36-50% at entry will receive His/LBB pacemaker which includes implantation of two leads, an endocardial right atrial lead, and an endocardial His-bundle or left bundle branch pacing lead directly pacing the intrinsic conduction system.

Pacing at the level His-Bundle or left bundle branch is used to correct the underlying conduction abnormality, resulting in a faster and more homogeneous activation of the heart pacing directly via the intrinsic conduction system of the heart accompanied by a right atrial endocardial lead and a right ventricular defibrillator endocardial lead for LVEF≤35% and by a right atrial endocardial lead for LVEF 36-50%.

有源比较器:Biventricular Pacing (BiVP)

Patients with LVEF≤35% at entry will receive a BiV defibrillator which includes implantation of three leads, an endocardial right atrial lead, an endocardial right ventricular ICD lead, and and an epicardial left ventricular lead implanted in a branch of the coronary sinus.

Patients with LVEF 36-50% at entry will receive BiV pacemaker which includes implantation of three leads, an endocardial right atrial lead, an endocardial right ventricular pacing lead, and and an epicardial left ventricular lead implanted in a branch of the coronary sinus.

Biventricular pacing has been shown to improve outcomes by delivering synchronized electrical stimuli to the right and left ventricles utilizing an an endocardial right atrial lead, an endocardial right ventricular lead, and an epicardial left ventricular lead implanted in a branch of the coronary sinus.

For LVEF≤35% a biventricular pacemaker-defibrillator will be implanted while for LVEF 36-50% a biventricular pacemaker will be implanted.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
A combined clinical endpoint of all-cause mortality and hospitalization for heart failure
大体时间:5.5 years

The primary efficacy outcome will be described using Kaplan-Meier freedom from event curves over time, with event-free survival compared between assigned treatment arms using a logrank test, stratified by levels of the two factors (LVEF (≤35% vs. 36 to 50%) and conduction abnormality (LBBB vs non-LBBB)) used for randomization.

5.5 years

次要结果测量

结果测量
措施说明
大体时间
Assess change in Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) at 12 months
大体时间:12 months

Assess change in Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) item score measured before and at 12 months after implant.

12 months
Change in composite endpoint comprised of death, first hospitalization for worsening HF and left ventricular end systolic volume index (LVESVi) at 5.5 years
大体时间:5.5 years

Secondary endpoint measured from all cause death, first hospitalization for heart failure and echocardiography on left ventricular end-systolic volume index (LVESVi) in the His/LBBP vs. BIV-BiVP arm

5.5 years
Composite of cardiovascular death or heart transplant or durable left ventricular assist device or more > 15% increase in the LVESVi or change in KCCQ-12 at the end of the study using win ratio
大体时间:5.5 years

Secondary endpoint measured from cardiovascular death or heart transplant or durable left ventricular assist device or more > 15% increase in the LVESVi or change in KCCQ-12 at the end of the study using win ratio

5.5 years
Death from any cause at 5.5 years
大体时间:5.5 years

Secondary endpoint measured from all cause death

5.5 years
Death from any cardiovascular cause at 5.5 years
大体时间:5.5 years

Secondary endpoint measured from death due to cardiovascular causes

5.5 years
Hospitalization for heart failure at 5.5 years
大体时间:5.5 years

Secondary endpoint measured from first hospitalization for heart failure

5.5 years
Cardiovascular hospitalization at 5.5 years
大体时间:5.5 years

Secondary endpoint measured from first hospitalization for cardiovascular disease

5.5 years
Total HF hospitalizations
大体时间:5.5 years

Total number of HF hospitalizations

5.5 years
Composite of cardiovascular death or first HF hospitalization
大体时间:5.5 years

Secondary endpoint measured from cardiovascular death, first hospitalization for heart failure

5.5 years
Composite cardiovascular death or HF hospitalization or heart transplant or durable left ventricular assist device
大体时间:5.5 years

Secondary endpoint measured from cardiovascular death, heart transplant or durable left ventricular assist device

5.5 years
Change in NYHA Classification at 12 months
大体时间:12 months

Secondary endpoint measured from New York Heart Association class

12 months
Change in Six Minute Walk Test performance at 12 months
大体时间:12 months

Secondary endpoint measured from Six Minute Walk Test

12 months
Patient activity measured through cardiovascular implantable electronic devices (CIED) at 12 months
大体时间:12 months

Measurement Patient activity measured through cardiovascular implantable electronic devices (CIED)

12 months
Change in NT-proBNP at 12 months
大体时间:12 months

Measurement of heart failure serum biomarker NT-proBNP

12 months

其他结果措施

结果测量
措施说明
大体时间
Appropriate ICD therapy for ventricular arrhythmias
大体时间:5.5 years

Antitachycardia pacing or ICD shocks

5.5 years
Incidence of atrial tachyarrhythmia events
大体时间:5.5 years

Atrial arrhythmia event measured through cIED

5.5 years
Change in Left Ventricular Ejection Fraction (LVEF) at 12 months
大体时间:12 months

Measurement of LVEF before and at 12 months after implant using echocardiography

12 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Mihail G Chelu, MD, PhD、Baylor College of Medicine
  • 首席研究员:Kenneth A Ellenbogen, MD、Virginia Commonwealth University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2023年9月13日

初级完成 (估计的)

2029年6月30日

研究完成 (估计的)

2029年6月30日

研究注册日期

首次提交

2022年11月24日

首先提交符合 QC 标准的

2022年12月6日

首次发布 (实际的)

2022年12月14日

研究记录更新

最后更新发布 (实际的)

2026年11月12日

上次提交的符合 QC 标准的更新

2026年11月8日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

是的

在美国制造并从美国出口的产品

是的

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅